|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0031809,
umls-concept:C0031928,
umls-concept:C0034380,
umls-concept:C0036525,
umls-concept:C0175659,
umls-concept:C0205245,
umls-concept:C0222045,
umls-concept:C0349674,
umls-concept:C0684249,
umls-concept:C1512162,
umls-concept:C1516213,
umls-concept:C1522484,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1988-12-22
|
|
pubmed:abstractText |
Quality of life is an important factor in the assessment of cancer therapy, but it is difficult to define and measure. The Functional Living Index-Cancer (FLIC) was designed specifically for cancer patients under treatment. The Eastern Cooperative Oncology Group (ECOG) mounted a pilot study to assess the feasibility and sensitivity of the patient-oriented FLIC scale for assessment of quality of life. The results of this study show that the FLIC scores correlate with the functional status of patients on treatment: high scores on the FLIC prior to therapy were found to correlate with good performance status (p = 0.0001), and decreases in the FLIC score during therapy correlated with a decline in performance status (p = 0.0001), with poor performance status (p = 0.0002), and greater than 5% recent weight loss (p = 0.004). However, there was poor compliance to completion of the instrument, indicating a need for future research into this aspect of assessing quality of life in the cooperative group setting.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycins,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine,
http://linkedlifedata.com/resource/pubmed/chemical/iproplatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0277-3732
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
630-3
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:3055933-Adult,
pubmed-meshheading:3055933-Aged,
pubmed-meshheading:3055933-Aged, 80 and over,
pubmed-meshheading:3055933-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3055933-Carboplatin,
pubmed-meshheading:3055933-Clinical Trials as Topic,
pubmed-meshheading:3055933-Cyclophosphamide,
pubmed-meshheading:3055933-Doxorubicin,
pubmed-meshheading:3055933-Humans,
pubmed-meshheading:3055933-Lung Neoplasms,
pubmed-meshheading:3055933-Male,
pubmed-meshheading:3055933-Methotrexate,
pubmed-meshheading:3055933-Middle Aged,
pubmed-meshheading:3055933-Mitomycin,
pubmed-meshheading:3055933-Mitomycins,
pubmed-meshheading:3055933-Organoplatinum Compounds,
pubmed-meshheading:3055933-Patient Participation,
pubmed-meshheading:3055933-Procarbazine,
pubmed-meshheading:3055933-Progesterone,
pubmed-meshheading:3055933-Quality of Life,
pubmed-meshheading:3055933-Vinblastine
|
|
pubmed:year |
1988
|
|
pubmed:articleTitle |
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study.
|
|
pubmed:affiliation |
Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
